What is Harte Hanks' operating income?

Harte Hanks' total operating income in 2025 was $386 thousand, based on the following breakdown: Total Gross Profit: $78.75 million Total Operating Expenses: $78.36 million

Harte Hanks (HHS) Financials

$2.32 -0.13 (-5.31%)

Closing price 04:00 PM Eastern

Extended Trading

$2.38 +0.06 (+2.37%)

As of 04:10 PM Eastern

Compare

Annual Income Statements for Harte Hanks

This table shows Harte Hanks' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Income / (Loss) Attributable to Common Shareholders	-171	-131	-42	15	-27	-2.19	13	35	-1.57	-30	-0.81
Consolidated Net Income / (Loss)	-171	-131	-42	18	-26	-1.69	15	37	-1.57	-30	-0.81
Net Income / (Loss) Continuing Operations	-181	-90	-42	18	-26	-1.69	15	37	-1.57	-30	-0.81
Total Pre-Tax Income	-218	-69	-52	-0.56	-25	-18	16	19	-1.92	-38	-1.01
Total Operating Income	-198	-54	-41	-26	-22	-11	7.64	15	3.36	2.09	0.39
Total Gross Profit	211	159	154	121	96	73	85	102	94	91	79
Total Revenue	444	404	384	285	218	177	195	206	191	185	160
Operating Revenue	444	404	384	285	218	177	195	206	191	185	160
Total Cost of Revenue	233	245	230	164	122	104	110	105	98	94	81
Operating Cost of Revenue	233	245	230	164	122	104	110	105	98	94	81
Total Operating Expenses	409	213	194	147	117	84	77	87	90	89	78
Selling, General & Admin Expense	45	45	40	34	24	22	18	22	21	23	22
Marketing Expense	142	117	109	100	76	49	50	62	60	57	50
Depreciation Expense	12	12	11	7.45	5.34	3.62	2.56	2.73	4.24	4.39	4.47
Impairment Charge	210	39	35	4.89	-	-	-	-	0.00	3.17	0.00
Restructuring Charge	-	-	-	0.00	12	9.37	6.36	0.00	5.69	2.40	1.78
Total Other Income / (Expense), net	-20	-15	-11	25	-2.91	-7.73	8.62	4.21	-5.28	-40	-1.39
Interest Expense	5.02	3.45	4.83	1.55	1.26	1.16	-9.10	0.44	0.00	38	0.00
Interest & Investment Income	-	-	-	-	-	-	-	-	0.14	-0.19	-0.25
Other Income / (Expense), net	-15	-12	-6.06	27	-1.64	-6.57	-0.48	4.64	-5.41	-2.34	-1.15
Income Tax Expense	-37	21	-9.89	-18	1.75	-17	1.29	-17	-0.35	-7.64	-0.20
Basic Earnings per Share	($27.73)	($21.29)	($6.76)	-	($4.26)	($0.34)	$1.85	$4.98	($0.21)	($4.15)	($0.11)
Weighted Average Basic Shares Outstanding	6.16M	6.15M	6.19M	6.24M	6.28M	6.47M	6.80M	7.10M	7.31M	7.29M	7.39M
Diluted Earnings per Share	($27.73)	($21.29)	($6.76)	$2.38	($4.26)	($0.34)	$1.76	$4.75	($0.21)	($4.15)	($0.11)
Weighted Average Diluted Shares Outstanding	6.16M	6.15M	6.19M	6.27M	6.28M	6.47M	7.21M	7.46M	7.31M	7.29M	7.39M
Weighted Average Basic & Diluted Shares Outstanding	61.70M	61.65M	6.22M	6.27M	6.31M	6.65M	7.00M	7.42M	7.24M	7.36M	7.41M

This table shows Harte Hanks' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
Net Income / (Loss) Attributable to Common Shareholders	0.62	-1.98	-0.17	-28	0.14	-2.43	-0.39	-0.34	-2.29	2.20	-0.63
Consolidated Net Income / (Loss)	0.62	-1.98	-0.17	-28	0.14	-2.43	-0.39	-0.34	-2.29	2.20	-0.63
Net Income / (Loss) Continuing Operations	0.62	-1.98	-0.17	-28	0.14	-2.43	-0.39	-0.34	-2.29	2.20	-0.63
Total Pre-Tax Income	2.53	-3.95	-0.24	-37	1.01	-1.86	-0.61	-0.41	0.32	-0.31	-1.00
Total Operating Income	2.91	-2.28	0.38	1.37	1.90	-1.55	-0.04	0.03	0.51	-0.12	-0.77
Total Gross Profit	24	26	22	22	23	24	22	19	19	19	17
Total Revenue	47	49	45	45	48	47	42	39	40	40	37
Operating Revenue	47	49	45	45	48	47	42	39	40	40	37
Total Cost of Revenue	23	24	23	23	24	23	20	19	20	21	20
Operating Cost of Revenue	23	24	23	23	24	23	20	19	20	21	20
Total Operating Expenses	21	28	22	21	22	25	22	19	19	19	18
Selling, General & Admin Expense	4.92	4.60	5.94	5.85	5.26	5.73	5.84	5.54	5.15	5.68	5.64
Marketing Expense	15	16	14	14	14	15	14	12	12	12	11
Depreciation Expense	0.95	1.19	1.05	1.02	1.04	1.28	1.06	1.07	1.22	1.13	1.08
Restructuring Charge	0.00	5.69	0.85	0.43	0.84	0.29	0.84	0.15	0.54	0.26	0.16
Total Other Income / (Expense), net	-0.38	-1.67	-0.62	-38	-0.89	-0.31	-0.57	-0.45	-0.19	-0.19	-0.23
Interest & Investment Income	-0.00	-	-0.01	-0.04	-0.06	-0.08	-0.05	-0.06	-0.08	-0.05	-0.07
Other Income / (Expense), net	-0.38	-1.65	-0.61	0.05	-0.83	-0.94	-0.51	-0.39	-0.11	-0.14	-0.16
Income Tax Expense	1.91	-1.97	-0.07	-9.00	0.87	0.57	-0.22	-0.08	2.61	-2.51	-0.37
Basic Earnings per Share	$0.09	($0.27)	($0.02)	($3.84)	$0.02	($0.31)	($0.05)	($0.05)	($0.31)	$0.30	($0.08)
Weighted Average Basic Shares Outstanding	7.24M	7.31M	7.24M	7.26M	7.32M	7.29M	7.36M	7.38M	7.42M	7.39M	7.42M
Diluted Earnings per Share	$0.08	($0.26)	($0.02)	($3.84)	$0.02	($0.31)	($0.05)	($0.05)	($0.31)	$0.30	($0.08)
Weighted Average Diluted Shares Outstanding	7.31M	7.31M	7.24M	7.26M	7.40M	7.29M	7.36M	7.38M	7.42M	7.39M	7.42M
Weighted Average Basic & Diluted Shares Outstanding	7.22M	7.24M	7.24M	7.29M	7.29M	7.36M	7.36M	7.41M	7.41M	7.41M	7.42M

This table details how cash moves in and out of Harte Hanks' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Change in Cash & Equivalents	-37	29	-38	12	13	-0.56	-18	-3.77	7.50	-8.93	-4.35
Net Cash From Operating Activities	33	15	-31	-9.18	12	-7.84	-1.76	29	10	-2.99	-1.74
Net Cash From Continuing Operating Activities	17	50	-31	-9.18	12	-7.84	-1.76	29	10	-2.99	-1.74
Net Income / (Loss) Continuing Operations	-181	-90	-42	18	-26	-1.69	15	37	-1.57	-30	-0.81
Consolidated Net Income / (Loss)	-171	-131	-42	18	-26	-1.69	15	37	-1.57	-30	-0.81
Depreciation Expense	12	12	9.79	7.34	5.34	3.62	2.56	2.73	4.24	4.39	4.47
Non-Cash Adjustments To Reconcile Net Income	227	44	42	-26	8.65	-3.18	-8.34	-3.93	2.94	36	-2.84
Changes in Operating Assets and Liabilities, net	-42	83	-42	-7.98	24	-6.59	-11	-6.79	4.87	-13	-2.55
Net Cash From Investing Activities	-36	100	-5.67	-0.05	-2.60	-0.78	-2.90	-11	-2.31	-3.74	-2.76
Net Cash From Continuing Investing Activities	-33	-9.44	-5.67	-0.05	-2.60	-0.78	-2.90	-11	-2.31	-3.74	-2.76
Purchase of Property, Plant & Equipment	-7.98	-6.69	-5.68	-4.21	-2.90	-2.70	-3.05	-5.80	-2.81	-3.75	-2.76
Sale of Property, Plant & Equipment	-	0.76	0.02	0.23	0.30	1.92	0.15	0.06	0.00	0.00	0.00
Net Cash From Financing Activities	-32	-85	-1.46	23	3.09	7.31	-13	-16	-3.22	-0.42	0.51
Net Cash From Continuing Financing Activities	-32	-85	-1.46	23	3.09	7.31	-13	-16	-3.22	-0.42	0.51
Repayment of Debt	-18	-356	-31	-10	-0.62	-2.25	-18	-5.13	-0.05	0.00	-0.10
Other Financing Activities, net	0.01	0.00	-	-	-0.79	-0.43	-0.52	-0.66	-0.80	-0.42	0.61
Effect of Exchange Rate Changes	-1.98	0.44	0.32	-1.01	-	-	-0.35	-5.25	2.55	-1.78	-0.37
Cash Interest Paid	1.68	5.67	0.29	0.20	0.88	0.65	0.49	0.27	0.24	0.23	0.29
Cash Income Taxes Paid	10	2.59	33	-0.12	19	9.22	1.32	-	2.90	1.45	1.78

This table details how cash moves in and out of Harte Hanks' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
Net Change in Cash & Equivalents	-0.08	4.58	-6.90	-0.49	-5.03	3.49	-0.95	-4.23	1.75	-0.92	-1.05
Net Cash From Operating Activities	1.52	4.37	-5.69	1.61	-2.95	4.05	-0.82	-4.85	3.20	0.74	-0.58
Net Cash From Continuing Operating Activities	1.52	4.37	-5.69	1.61	-2.95	4.05	-0.82	-4.85	3.20	0.74	-0.58
Net Income / (Loss) Continuing Operations	0.62	-1.98	-0.17	-28	0.14	-2.43	-0.39	-0.34	-2.29	2.20	-0.63
Consolidated Net Income / (Loss)	0.62	-1.98	-0.17	-28	0.14	-2.43	-0.39	-0.34	-2.29	2.20	-0.63
Depreciation Expense	0.95	1.19	1.05	1.02	1.04	1.28	1.06	1.07	1.22	1.13	1.08
Non-Cash Adjustments To Reconcile Net Income	-0.22	1.50	0.39	32	-0.44	3.35	-0.52	-0.57	-1.29	-0.46	-0.32
Changes in Operating Assets and Liabilities, net	0.17	3.66	-6.96	-3.92	-3.69	1.85	-0.97	-5.01	5.55	-2.13	-0.71
Net Cash From Investing Activities	-0.22	-0.83	-0.53	-0.68	-1.91	-0.63	-0.10	-0.23	-1.01	-1.42	-0.35
Net Cash From Continuing Investing Activities	-0.22	-0.83	-0.53	-0.68	-1.91	-0.63	-0.10	-0.23	-1.01	-1.42	-0.35
Purchase of Property, Plant & Equipment	-0.22	-1.33	-0.53	-0.68	-1.91	-0.63	-0.11	-0.22	-1.01	-1.42	-0.35
Sale of Property, Plant & Equipment	0.00	-	0.00	-	-	0.00	0.00	-0.00	-	0.00	0.00
Net Cash From Financing Activities	-0.82	-0.09	-0.15	-0.01	-0.16	-0.09	-0.07	0.78	-0.16	-0.04	-0.05
Net Cash From Continuing Financing Activities	-0.82	-0.09	-0.15	-0.01	-0.16	-0.09	-0.07	0.78	-0.16	-0.04	-0.05
Other Financing Activities, net	-0.33	-0.05	-0.10	-0.06	-0.16	-0.09	-0.07	0.78	-0.06	-0.04	-0.05
Effect of Exchange Rate Changes	-0.56	1.13	-0.53	-1.40	-0.01	0.17	0.04	0.07	-0.28	-0.20	-0.08
Cash Interest Paid	0.03	0.05	-0.04	-0.01	0.01	0.27	0.06	0.05	0.06	0.16	0.05
Cash Interest Received	-	-	-	-	-	-	-0.02	-	-	-	-0.00
Cash Income Taxes Paid	1.30	6.27	0.17	0.72	0.31	0.26	0.20	0.99	0.31	0.28	0.30

This table presents Harte Hanks' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Total Assets	414	213	131	125	110	119	108	120	123	102	92
Total Current Assets	307	149	103	105	79	86	75	66	65	54	46
Restricted Cash	-	-	-	0.00	6.02	4.15	3.22	-	-	9.93	5.59
Accounts Receivable	104	89	81	54	39	42	49	48	42	40	35
Prepaid Expenses	7.91	5.94	5.04	4.09	3.30	2.26	1.95	2.18	1.92	1.51	2.36
Current Deferred & Refundable Income Taxes	1.76	2.90	3.89	20	0.08	7.39	7.46	4.26	1.76	0.94	1.43
Other Current Assets	6.66	4.93	3.90	4.90	2.48	1.50	1.65	1.61	0.93	1.37	2.37
Plant, Property, & Equipment, net	28	24	22	14	8.32	5.88	7.75	11	8.86	8.96	8.39
Total Noncurrent Assets	79	40	5.82	6.59	23	27	25	43	49	39	37
Noncurrent Note & Lease Receivables	-	-	-	-	-	-	-	-	-	-	0.61
Goodwill	70	35	-	-	-	-	0.00	2.40	1.93	0.30	0.30
Intangible Assets	4.12	3.30	2.59	-	-	-	0.00	3.54	2.82	0.56	0.37
Noncurrent Deferred & Refundable Income Taxes	3.00	-	-	-	-	-	0.00	16	17	15	16
Other Noncurrent Operating Assets	2.44	2.27	3.23	6.59	23	27	25	21	27	23	20
Total Liabilities & Shareholders' Equity	414	213	131	125	110	119	108	120	123	102	92
Total Liabilities	274	211	165	135	150	163	123	101	103	80	71
Total Current Liabilities	98	105	67	54	46	47	42	44	48	35	30
Accounts Payable	37	46	36	31	17	16	16	22	23	13	13
Accrued Expenses	-	-	-	-	-	-	-	-	-	8.40	5.92
Customer Deposits	13	7.99	11	6.73	9.77	6.50	6.50	1.22	1.82	1.63	0.87
Current Deferred Revenue	6.24	6.51	5.34	6.03	4.40	4.66	3.94	4.59	3.20	1.59	0.81
Current Employee Benefit Liabilities	7.42	9.99	11	6.78	4.22	5.25	7.03	6.68	5.62	3.21	2.75
Other Current Liabilities	6.34	4.19	3.73	3.56	10	9.57	8.84	8.61	14	6.88	6.72
Total Noncurrent Liabilities	176	106	98	80	105	116	80	58	55	45	41
Noncurrent Employee Benefit Liabilities	55	61	59	62	70	67	52	38	29	23	21
Other Noncurrent Operating Liabilities	26	34	38	4.06	16	26	23	20	26	22	20
Total Equity & Noncontrolling Interests	140	2.66	-35	-19	-50	-53	-25	19	20	22	21
Total Preferred & Common Equity	140	2.66	-35	-19	-50	-53	-25	19	20	22	21
Total Common Equity	140	2.66	-35	-19	-50	-53	-25	19	20	22	21
Common Stock	473	471	469	466	459	395	303	231	170	136	122
Retained Earnings	974	837	795	813	798	796	811	846	845	815	814
Treasury Stock	-1,263	-1,259	-1,254	-1,251	-1,244	-1,179	-1,085	-1,010	-951	-916	-900
Accumulated Other Comprehensive Income / (Loss)	-44	-46	-44	-46	-63	-66	-53	-48	-44	-14	-15

This table presents Harte Hanks' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2023	Q1 2024	Q2 2024	Q3 2024	Q1 2025	Q2 2025	Q3 2025	Q1 2026
Period end date	9/30/2023	3/31/2024	6/30/2024	9/30/2024	3/31/2025	6/30/2025	9/30/2025	3/31/2026
Total Assets	111	113	110	108	101	95	93	90
Total Current Assets	62	58	55	54	54	50	49	46
Cash & Equivalents	13	11	11	5.94	8.98	4.76	6.51	4.54
Accounts Receivable	44	41	39	43	40	41	37	34
Prepaid Expenses	2.72	2.22	2.33	2.12	2.14	2.72	2.02	3.02
Current Deferred & Refundable Income Taxes	1.22	1.76	1.76	1.76	0.94	0.94	0.94	1.86
Other Current Assets	1.31	1.27	1.29	1.47	1.30	0.95	1.74	2.20
Plant, Property, & Equipment, net	9.28	8.41	8.43	9.31	8.53	7.95	7.90	7.79
Total Noncurrent Assets	39	47	46	45	38	37	36	37
Noncurrent Note & Lease Receivables	-	-	-	-	-	-	-	0.56
Goodwill	2.43	1.93	1.93	1.93	0.30	0.30	0.30	0.30
Intangible Assets	3.00	2.64	2.46	2.28	0.51	0.47	0.42	0.32
Noncurrent Deferred & Refundable Income Taxes	16	17	17	17	15	15	15	16
Other Noncurrent Operating Assets	18	26	25	24	22	21	20	20
Total Liabilities & Shareholders' Equity	111	113	110	108	101	95	93	90
Total Liabilities	90	93	89	87	79	73	73	70
Total Current Liabilities	39	40	36	37	36	31	33	31
Accounts Payable	19	16	20	21	22	19	18	11
Accrued Expenses	-	-	-	-	-	-	-	6.10
Customer Deposits	1.45	1.60	1.32	1.43	1.64	1.44	0.77	0.85
Current Deferred Revenue	5.68	3.71	3.48	3.40	2.48	1.81	2.46	2.57
Current Employee Benefit Liabilities	4.94	4.75	4.41	4.48	3.57	3.73	3.83	3.32
Other Current Liabilities	8.10	14	6.94	6.76	6.42	5.63	7.83	6.79
Total Noncurrent Liabilities	52	53	53	50	43	42	40	40
Noncurrent Employee Benefit Liabilities	36	29	28	27	22	21	20	20
Other Noncurrent Operating Liabilities	16	25	25	23	21	20	19	19
Total Equity & Noncontrolling Interests	21	20	21	21	21	22	20	20
Total Preferred & Common Equity	21	20	21	21	21	22	20	20
Total Common Equity	21	20	21	21	21	22	20	20
Common Stock	172	165	158	137	134	124	122	120
Retained Earnings	847	845	817	817	814	814	812	813
Treasury Stock	-954	-946	-938	-917	-913	-902	-900	-899
Accumulated Other Comprehensive Income / (Loss)	-45	-44	-17	-16	-13	-13	-13	-15

This table displays calculated financial ratios and metrics derived from Harte Hanks' official financial filings.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
DEI Shares Outstanding	61,249,900.00	61,602,233.00	62,068,179.00	6,254,023.00	6,300,381.00	6,549,309.00	6,976,144.00	7,218,033.00	7,216,314.00	7,288,983.00	7,414,794.00
DEI Adjusted Shares Outstanding	6,124,990.00	6,160,223.00	6,206,818.00	6,254,023.00	6,300,381.00	6,549,309.00	6,976,144.00	7,218,033.00	7,216,314.00	7,288,983.00	7,414,794.00
DEI Earnings Per Adjusted Shares Outstanding	-27.91	-21.26	-6.74	2.38	-4.25	-0.33	1.81	4.90	-0.22	-4.16	-0.11
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-11.07%	-8.95%	-5.07%	-25.86%	-23.56%	-18.70%	10.00%	6.00%	-7.17%	-3.26%	-13.86%
EBITDA Growth	-636.12%	73.52%	31.45%	123.17%	-312.16%	24.45%	171.85%	131.24%	-90.29%	89.78%	-10.40%
EBIT Growth	-982.41%	69.22%	28.57%	102.11%	-2,450.76%	26.25%	141.77%	175.77%	-110.40%	88.22%	-214.05%
NOPAT Growth	-951.88%	72.80%	24.10%	36.29%	17.01%	51.05%	195.01%	308.98%	-91.83%	-37.69%	-81.56%
Net Income Growth	-812.47%	23.40%	68.03%	141.93%	-249.65%	93.55%	983.77%	145.65%	-104.27%	-1,829.75%	97.32%
EPS Growth	-812.47%	23.40%	68.03%	135.21%	-278.99%	92.02%	617.65%	169.89%	-104.42%	-1,876.19%	97.35%
Operating Cash Flow Growth	27.94%	-56.17%	-311.10%	70.19%	231.76%	-164.81%	77.51%	1,733.13%	-63.61%	-128.51%	41.92%
Free Cash Flow Firm Growth	618.76%	-60.80%	-337.58%	149.64%	-66.95%	-153.59%	-36.99%	72.87%	293.71%	-194.57%	66.88%
Invested Capital Growth	-84.06%	-177.11%	273.13%	-121.51%	-243.07%	9.97%	49.61%	133.61%	-82.32%	687.34%	27.09%
Revenue Q/Q Growth	2.95%	1.27%	-2.60%	-9.44%	-7.59%	-2.88%	2.59%	1.37%	-2.69%	-1.26%	-4.36%
EBITDA Q/Q Growth	-0.24%	-458.83%	22.29%	142.12%	16.15%	-10.87%	89.49%	0.95%	-72.76%	58.37%	128.43%
EBIT Q/Q Growth	-0.73%	-191.93%	18.66%	103.50%	13.73%	-4.36%	192.09%	-0.81%	-151.36%	85.57%	74.66%
NOPAT Q/Q Growth	3.16%	-293.29%	2.00%	52.99%	18.05%	-8.08%	29.00%	128.76%	-95.30%	53.00%	136.76%
Net Income Q/Q Growth	-4.62%	-1,163.38%	67.94%	230.68%	-21.15%	70.20%	4.99%	119.85%	-107.07%	-1.53%	85.11%
EPS Q/Q Growth	-4.62%	-1,163.38%	67.94%	208.68%	-9.51%	67.62%	0.00%	138.69%	-106.86%	-1.22%	84.72%
Operating Cash Flow Q/Q Growth	-7.64%	-54.16%	42.86%	-321.07%	67.85%	10.00%	24.82%	8.95%	-17.18%	-12.08%	-210.30%
Free Cash Flow Firm Q/Q Growth	369.54%	-58.10%	-2,124.19%	386.69%	290.41%	-93.71%	-319.88%	48.79%	-69.53%	-26.91%	-391.38%
Invested Capital Q/Q Growth	-70.09%	-241.42%	1,394.19%	15.53%	-26.60%	-13.52%	26.65%	168.65%	-79.31%	-22.18%	11.74%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	47.47%	39.34%	40.02%	42.43%	44.00%	41.39%	43.52%	49.28%	48.84%	49.38%	49.35%
EBITDA Margin	-45.18%	-13.14%	-9.49%	2.97%	-8.23%	-7.65%	5.00%	10.90%	1.14%	2.24%	2.33%
Operating Margin	-44.57%	-13.31%	-10.64%	-9.15%	-9.93%	-5.98%	3.93%	7.32%	1.75%	1.13%	0.24%
EBIT Margin	-48.05%	-16.24%	-12.22%	0.35%	-10.69%	-9.69%	3.68%	9.57%	-1.07%	-0.13%	-0.48%
Profit (Net Income) Margin	-38.48%	-32.38%	-10.90%	6.17%	-12.07%	-0.96%	7.69%	17.83%	-0.82%	-16.36%	-0.51%
Tax Burden Percent	78.25%	189.36%	80.88%	-3,122.78%	107.15%	9.25%	92.08%	190.42%	81.81%	79.87%	80.46%
Interest Burden Percent	102.35%	105.26%	110.28%	-56.83%	105.43%	106.79%	227.02%	97.78%	93.43%	15,675.21%	132.63%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	7.92%	-90.42%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	-67.79%	-585.87%	-180.47%	-61.87%	0.00%	0.00%	0.00%	0.00%	47.32%	22.12%	2.02%
ROIC Less NNEP Spread (ROIC-NNEP)	43.49%	-442.52%	-177.01%	-71.72%	0.00%	0.00%	0.00%	0.00%	74.62%	246.60%	15.96%
Return on Net Nonoperating Assets (RNNOA)	-5.42%	402.70%	169.98%	66.34%	0.00%	0.00%	0.00%	0.00%	-55.45%	-167.97%	-5.87%
Return on Equity (ROE)	-73.20%	-183.16%	-10.49%	4.47%	106.29%	4.06%	-51.28%	1,927.46%	-8.12%	-145.85%	-3.84%
Cash Return on Invested Capital (CROIC)	77.21%	0.00%	-195.88%	0.00%	0.00%	0.00%	0.00%	-56.87%	187.23%	-132.80%	-21.83%
Operating Return on Assets (OROA)	-40.32%	-20.93%	-30.90%	0.92%	-19.75%	-14.93%	6.30%	17.34%	-1.69%	-0.22%	-0.79%
Return on Assets (ROA)	-32.29%	-41.71%	-27.56%	16.29%	-22.32%	-1.48%	13.17%	32.28%	-1.29%	-26.99%	-0.84%
Return on Common Equity (ROCE)	-73.20%	-183.16%	-10.49%	4.41%	148.11%	5.01%	-68.35%	-2,983.63%	-8.12%	-145.85%	-3.84%
Return on Equity Simple (ROE_SIMPLE)	-121.82%	-4,929.86%	-5.26%	-91.48%	52.86%	3.19%	-60.57%	195.53%	-7.91%	0.00%	0.00%
Net Operating Profit after Tax (NOPAT)	-139	-38	-29	-18	-15	-7.40	7.03	29	2.35	1.47	0.27
NOPAT Margin	-31.20%	-9.32%	-7.45%	-6.40%	-6.95%	-4.19%	3.61%	13.95%	1.23%	0.79%	0.17%
Net Nonoperating Expense Percent (NNEP)	-111.27%	-143.35%	-3.46%	9.84%	-100.79%	52.18%	95.66%	78.15%	-27.30%	-224.48%	-13.93%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-	-	11.84%	6.76%	1.32%
Cost of Revenue to Revenue	52.53%	60.66%	59.98%	57.57%	56.00%	58.61%	56.48%	50.72%	51.16%	50.62%	50.65%
SG&A Expenses to Revenue	10.04%	11.08%	10.52%	12.02%	11.16%	12.17%	9.18%	10.61%	10.80%	12.30%	13.92%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	92.04%	52.66%	50.66%	51.58%	53.93%	47.37%	39.59%	41.96%	47.09%	48.25%	49.11%
Earnings before Interest and Taxes (EBIT)	-213	-66	-47	0.99	-23	-17	7.16	20	-2.05	-0.24	-0.76
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-201	-53	-36	8.44	-18	-14	9.72	22	2.18	4.14	3.71
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	1.38	35.02	0.07	0.00	0.00	0.00	0.00	4.49	2.47	1.73	1.09
Price to Tangible Book Value (P/TBV)	2.90	0.00	0.07	0.00	0.00	0.00	0.00	6.56	3.24	1.80	1.12
Price to Revenue (P/Rev)	0.43	0.23	0.15	0.05	0.10	0.10	0.27	0.41	0.26	0.20	0.14
Price to Earnings (P/E)	0.00	0.00	0.00	1.02	0.00	0.00	4.20	2.38	0.00	0.00	0.00
Dividend Yield	10.78%	22.52%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	98.39%	0.00%	0.00%	23.80%	41.95%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	4.51	0.00	0.78	0.00	0.00	0.00	0.00	8.77	20.52	2.35	1.12
Enterprise Value to Revenue (EV/Rev)	0.57	0.12	0.15	0.06	0.08	0.12	0.27	0.36	0.16	0.15	0.10
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	2.15	0.00	0.00	5.41	3.29	14.03	6.66	4.51
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	18.38	0.00	0.00	7.35	3.75	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	0.00	7.48	2.57	13.03	18.84	61.92
Enterprise Value to Operating Cash Flow (EV/OCF)	7.62	3.22	0.00	0.00	1.39	0.00	0.00	2.57	2.92	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	1.61	0.76	0.00	0.25	0.70	0.00	0.00	0.00	3.29	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.55	0.00	0.00	-1.50	-0.47	-0.62	-0.33	0.00	0.00	0.00	0.00
Long-Term Debt to Equity	0.53	0.00	0.00	-1.50	-0.47	-0.51	-0.33	0.00	0.00	0.00	0.00
Financial Leverage	-0.12	-0.91	-0.96	-0.93	0.45	0.26	0.28	-5.37	-0.74	-0.68	-0.37
Leverage Ratio	2.27	4.39	0.38	0.27	-4.76	-2.76	-3.89	59.71	6.28	5.40	4.59
Compound Leverage Factor	2.32	4.62	0.42	-0.16	-5.02	-2.94	-8.84	58.38	5.87	847.18	6.08
Debt to Total Capital	35.46%	0.00%	0.00%	299.64%	-87.96%	-166.26%	-50.04%	0.00%	0.00%	0.00%	0.00%
Short-Term Debt to Total Capital	1.38%	0.00%	0.00%	0.00%	0.00%	-30.22%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	34.08%	0.00%	0.00%	299.64%	-87.96%	-136.04%	-50.04%	0.00%	0.00%	0.00%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	205.17%	-45.73%	-59.65%	-97.31%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	64.54%	100.00%	100.00%	-404.81%	233.69%	325.91%	247.35%	100.00%	100.00%	100.00%	100.00%
Debt to EBITDA	-0.38	0.00	0.00	1.68	-1.04	-2.00	0.51	0.00	0.00	0.00	0.00
Net Debt to EBITDA	-0.30	0.00	0.00	-0.79	0.86	0.48	-1.04	0.00	0.00	0.00	0.00
Long-Term Debt to EBITDA	-0.37	0.00	0.00	1.68	-1.04	-1.64	0.51	0.00	0.00	0.00	0.00
Debt to NOPAT	-0.56	0.00	0.00	-0.78	-1.24	-3.66	0.71	0.00	0.00	0.00	0.00
Net Debt to NOPAT	-0.44	0.00	0.00	0.37	1.02	0.87	-1.44	0.00	0.00	0.00	0.00
Long-Term Debt to NOPAT	-0.53	0.00	0.00	-0.78	-1.24	-3.00	0.71	0.00	0.00	0.00	0.00
Altman Z-Score	3.69	6.89	18.18	11.94	11.87	10.79	13.18	12.87	11.59	13.52	14.52
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	1.24%	-39.35%	-23.33%	-33.30%	254.80%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	3.13	1.43	8.71	1.94	1.74	1.83	1.78	1.52	1.36	1.53	1.54
Quick Ratio	1.23	1.29	7.80	1.39	1.47	1.50	1.44	1.34	1.26	1.13	1.15
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	158	62	-147	73	24	-13	-18	-4.80	9.30	-8.80	-2.91
Operating Cash Flow to CapEx	416.96%	245.79%	-543.59%	-230.62%	466.17%	-1,011.61%	-60.79%	501.34%	372.98%	-79.78%	-62.95%
Free Cash Flow to Firm to Interest Expense	31.47	17.91	-30.46	47.05	19.11	-11.10	0.00	-10.96	0.00	-0.23	0.00
Operating Cash Flow to Interest Expense	6.64	4.22	-6.38	-5.92	9.59	-6.74	0.00	65.74	0.00	-0.08	0.00
Operating Cash Flow Less CapEx to Interest Expense	5.04	2.51	-7.56	-8.49	7.53	-7.40	0.00	52.62	0.00	-0.18	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.84	1.29	2.53	2.64	1.85	1.54	1.71	1.81	1.58	1.65	1.65
Accounts Receivable Turnover	3.88	4.20	4.63	4.33	4.67	4.39	4.29	4.25	4.25	4.51	4.29
Inventory Turnover	212.29	272.40	0.00	0.00	303.87	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	13.66	15.54	0.00	0.00	19.86	24.91	28.56	22.58	19.76	20.80	18.40
Accounts Payable Turnover	6.38	5.97	0.00	0.00	5.08	6.24	6.78	5.42	4.29	5.12	6.09
Days Sales Outstanding (DSO)	94.11	86.90	78.87	84.21	78.18	83.05	85.08	85.90	85.92	80.90	85.13
Days Inventory Outstanding (DIO)	1.72	1.34	0.00	0.00	1.20	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	57.18	61.14	0.00	0.00	71.84	58.46	53.84	67.33	85.02	71.24	59.89
Cash Conversion Cycle (CCC)	38.66	27.10	78.87	84.21	7.54	24.59	31.24	18.57	0.89	9.65	25.23
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	56	-43	75	-16	-55	-50	-25	8.44	1.49	12	15
Invested Capital Turnover	2.17	62.87	24.22	9.66	-6.08	-3.36	-5.19	-24.73	38.54	27.97	11.96
Increase / (Decrease) in Invested Capital	-296	-100	118	-91	-39	5.52	25	34	-6.95	10	3.18
Enterprise Value (EV)	254	47	59	18	17	21	53	74	31	28	17
Market Capitalization	193	93	59	15	23	18	53	84	49	38	22
Book Value per Share	$2.29	$0.04	$12.81	($3.07)	($7.89)	($8.11)	($3.54)	$2.61	$2.75	$2.98	$2.77
Tangible Book Value per Share	$1.09	($0.57)	$12.81	($3.07)	($7.89)	($8.11)	($3.54)	$1.78	$2.09	$2.86	$2.68
Total Capital	217	2.66	795	4.74	-21	-16	-9.99	19	20	22	21
Total Debt	77	0.00	0.00	14	19	27	5.00	0.00	0.00	0.00	0.00
Total Long-Term Debt	74	0.00	0.00	14	19	22	5.00	0.00	0.00	0.00	0.00
Net Debt	61	-46	0.00	-6.68	-15	-6.46	-10	-10	-18	-9.93	-5.59
Capital Expenditures (CapEx)	7.98	5.94	5.67	3.98	2.60	0.78	2.90	5.74	2.81	3.74	2.76
Debt-free, Cash-free Net Working Capital (DFCFNWC)	195	-1.24	76	30	-0.35	10	18	12	-1.26	8.54	11
Debt-free Net Working Capital (DFNWC)	212	45	76	51	34	44	33	23	17	18	16
Net Working Capital (NWC)	209	45	76	51	34	39	33	23	17	18	16
Net Nonoperating Expense (NNE)	32	93	13	-36	11	-5.71	-7.94	-8.01	3.92	32	1.08
Net Nonoperating Obligations (NNO)	-84	-46	-720	-6.68	-15	-6.46	-10	-10	-18	-9.93	-5.59
Total Depreciation and Amortization (D&A)	13	13	11	7.45	5.34	3.62	2.56	2.73	4.24	4.39	4.47
Debt-free, Cash-free Net Working Capital to Revenue	43.98%	-0.31%	19.85%	10.52%	-0.16%	5.88%	9.15%	6.00%	-0.66%	4.61%	6.62%
Debt-free Net Working Capital to Revenue	47.70%	11.07%	19.85%	17.86%	15.52%	24.86%	16.92%	11.03%	8.93%	9.97%	10.12%
Net Working Capital to Revenue	47.03%	11.07%	19.85%	17.86%	15.52%	22.07%	16.92%	11.03%	8.93%	9.97%	10.12%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($27.70)	($21.30)	($6.76)	$2.39	$0.00	($0.34)	$1.85	$4.98	($0.21)	($4.15)	($0.11)
Adjusted Weighted Average Basic Shares Outstanding	6.16M	6.15M	6.19M	6.24M	6.28M	6.47M	6.80M	7.10M	7.31M	7.29M	7.39M
Adjusted Diluted Earnings per Share	($27.70)	($21.30)	($6.76)	$2.38	($4.26)	($0.34)	$1.76	$4.75	($0.21)	($4.15)	($0.11)
Adjusted Weighted Average Diluted Shares Outstanding	6.16M	6.15M	6.19M	6.27M	6.28M	6.47M	7.21M	7.46M	7.31M	7.29M	7.39M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	6.13M	6.16M	6.22M	6.27M	6.31M	6.65M	7.00M	7.42M	7.24M	7.36M	7.41M
Normalized Net Operating Profit after Tax (NOPAT)	8.39	-11	-4.45	-15	-6.86	-0.84	13	11	6.33	5.36	1.52
Normalized NOPAT Margin	1.89%	-2.63%	-1.16%	-5.20%	-3.16%	-0.48%	6.62%	5.13%	3.31%	2.90%	0.95%
Pre Tax Income Margin	-49.18%	-17.10%	-13.48%	-0.20%	-11.27%	-10.35%	8.36%	9.36%	-1.00%	-20.48%	-0.63%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	-42.55	-19.02	-9.72	0.64	-18.42	-14.73	0.00	45.09	0.00	-0.01	0.00
NOPAT to Interest Expense	-27.63	-10.91	-5.93	-11.75	-11.98	-6.36	0.00	65.68	0.00	0.04	0.00
EBIT Less CapEx to Interest Expense	-44.14	-20.74	-10.90	-1.93	-20.48	-15.40	0.00	31.98	0.00	-0.11	0.00
NOPAT Less CapEx to Interest Expense	-29.22	-12.63	-7.10	-14.32	-14.04	-7.03	0.00	52.57	0.00	-0.06	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	-12.43%	-4.04%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	-15.66%	-4.21%	-0.27%	0.66%	-0.02%	0.00%	0.00%	0.00%	-150.96%	0.00%	0.00%

This table displays calculated financial ratios and metrics derived from Harte Hanks' official financial filings.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
DEI Shares Outstanding	7,210,875.00	7,216,314.00	7,240,905.00	7,240,905.00	7,288,983.00	7,288,983.00	7,357,450.00	7,364,430.00	7,414,794.00	7,414,794.00	7,414,794.00
DEI Adjusted Shares Outstanding	7,210,875.00	7,216,314.00	7,240,905.00	7,240,905.00	7,288,983.00	7,288,983.00	7,357,450.00	7,364,430.00	7,414,794.00	7,414,794.00	7,414,794.00
DEI Earnings Per Adjusted Shares Outstanding	0.09	-0.27	-0.02	-3.84	0.02	-0.33	-0.05	-0.05	-0.31	0.30	-0.08
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-12.56%	-9.65%	-3.55%	-5.71%	1.08%	-4.77%	-8.55%	-14.22%	-17.03%	-15.43%	-10.34%
EBITDA Growth	-61.51%	-188.95%	274.52%	27.62%	-39.53%	55.63%	-37.55%	-70.78%	-23.03%	171.35%	-69.94%
EBIT Growth	-70.11%	-285.25%	84.93%	61.32%	-57.84%	36.50%	-139.83%	-124.82%	-62.23%	89.70%	-67.69%
NOPAT Growth	-77.93%	-104.26%	-64.39%	-18.63%	-62.51%	31.83%	-110.67%	-97.52%	-1,466.91%	92.47%	-1,820.00%
Net Income Growth	-91.38%	-109.07%	78.38%	-4,898.97%	-77.02%	-23.12%	-129.24%	98.80%	-1,709.86%	190.47%	-60.20%
EPS Growth	-90.36%	-108.64%	81.82%	-4,900.00%	-75.00%	-19.23%	-150.00%	98.70%	-1,650.00%	196.77%	-60.00%
Operating Cash Flow Growth	-87.71%	-33.23%	-434.04%	-44.22%	-293.57%	-7.37%	85.63%	-401.62%	208.41%	-81.78%	29.71%
Free Cash Flow Firm Growth	-0.40%	38.40%	98.46%	91.20%	59.47%	-311.88%	-921.62%	-426.28%	74.91%	71.22%	7.69%
Invested Capital Growth	158.67%	-82.32%	8.30%	34.07%	109.33%	687.34%	46.38%	81.47%	-11.49%	27.09%	25.13%
Revenue Q/Q Growth	-1.35%	5.03%	-8.17%	-0.91%	5.76%	-1.05%	-11.81%	-7.05%	2.30%	0.86%	-6.51%
EBITDA Q/Q Growth	82.17%	-178.81%	129.69%	199.39%	-13.69%	-157.83%	141.79%	40.08%	127.35%	-46.39%	-82.39%
EBIT Q/Q Growth	187.94%	-255.31%	94.12%	713.85%	-24.75%	-333.93%	77.80%	36.46%	214.49%	-163.77%	-261.48%
NOPAT Q/Q Growth	-39.74%	-324.02%	116.46%	266.13%	-72.24%	-507.39%	97.42%	185.00%	-15,425.91%	97.75%	-556.41%
Net Income Q/Q Growth	6.55%	-419.90%	91.35%	-16,177.19%	100.51%	-1,814.08%	83.89%	14.54%	-582.39%	196.33%	-128.52%
EPS Q/Q Growth	0.00%	-425.00%	92.31%	-19,100.00%	100.52%	-1,650.00%	83.87%	0.00%	-520.00%	196.77%	-126.67%
Operating Cash Flow Q/Q Growth	-47.17%	186.74%	-230.34%	128.25%	-283.33%	237.21%	-120.22%	-492.91%	165.90%	-76.94%	-178.02%
Free Cash Flow Firm Q/Q Growth	-11.27%	128.49%	-107.25%	-282.73%	-412.62%	-48.90%	65.03%	-97.16%	75.56%	-70.76%	-12.18%
Invested Capital Q/Q Growth	0.42%	-79.31%	469.19%	13.37%	56.79%	-22.18%	5.82%	40.55%	-23.53%	11.74%	4.19%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	51.29%	51.74%	48.33%	49.63%	49.24%	50.29%	52.36%	49.66%	48.43%	46.82%	46.84%
EBITDA Margin	7.39%	-5.55%	1.79%	5.42%	4.42%	-2.58%	1.22%	1.85%	4.10%	2.18%	0.41%
Operating Margin	6.18%	-4.60%	0.83%	3.05%	3.98%	-3.30%	-0.10%	0.09%	1.29%	-0.29%	-2.06%
EBIT Margin	5.37%	-7.94%	-0.51%	3.15%	2.24%	-5.30%	-1.33%	-0.91%	1.02%	-0.64%	-2.49%
Profit (Net Income) Margin	1.31%	-3.99%	-0.38%	-61.81%	0.30%	-5.16%	-0.94%	-0.87%	-5.78%	5.52%	-1.69%
Tax Burden Percent	24.43%	50.10%	70.66%	75.56%	14.06%	130.58%	64.58%	81.11%	-716.61%	-717.26%	62.93%
Interest Burden Percent	99.96%	100.38%	104.76%	-2,597.88%	94.66%	74.68%	109.57%	117.33%	79.16%	119.46%	107.43%
Effective Tax Rate	75.57%	0.00%	0.00%	0.00%	85.94%	0.00%	0.00%	0.00%	816.61%	0.00%	0.00%
Return on Invested Capital (ROIC)	0.00%	-124.18%	13.42%	47.48%	9.42%	-64.51%	-1.17%	0.80%	-108.16%	-2.46%	-16.00%
ROIC Less NNEP Spread (ROIC-NNEP)	0.00%	-121.52%	16.94%	284.10%	10.72%	-54.99%	2.39%	5.36%	-130.02%	-31.89%	-14.66%
Return on Net Nonoperating Assets (RNNOA)	0.00%	90.29%	-10.18%	-168.00%	-4.96%	37.45%	-1.18%	-1.97%	39.56%	11.72%	4.77%
Return on Equity (ROE)	254.74%	-33.89%	3.24%	-120.52%	4.46%	-27.05%	-2.35%	-1.17%	-68.59%	9.27%	-11.22%
Cash Return on Invested Capital (CROIC)	423.02%	187.23%	15.00%	-9.27%	-62.11%	-132.80%	-26.43%	-56.14%	7.02%	-21.83%	-24.04%
Operating Return on Assets (OROA)	9.52%	-12.53%	-0.85%	5.25%	3.84%	-8.74%	-2.26%	-1.56%	1.69%	-1.06%	-4.05%
Return on Assets (ROA)	2.33%	-6.30%	-0.63%	-103.06%	0.51%	-8.52%	-1.60%	-1.48%	-9.61%	9.11%	-2.74%
Return on Common Equity (ROCE)	112.70%	-33.89%	3.24%	-120.52%	4.46%	-27.05%	-2.35%	-1.17%	-68.59%	9.27%	-11.22%
Return on Equity Simple (ROE_SIMPLE)	108.33%	0.00%	-4.76%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Net Operating Profit after Tax (NOPAT)	0.71	-1.59	0.26	0.96	0.27	-1.09	-0.03	0.02	-3.65	-0.08	-0.54
NOPAT Margin	1.51%	-3.22%	0.58%	2.13%	0.56%	-2.31%	-0.07%	0.06%	-9.23%	-0.21%	-1.44%
Net Nonoperating Expense Percent (NNEP)	-0.83%	-2.66%	-3.53%	-236.63%	-1.30%	-9.52%	-3.56%	-4.56%	21.87%	29.43%	-1.34%
Return On Investment Capital (ROIC_SIMPLE)	-	-8.03%	1.32%	4.66%	1.27%	-5.01%	-0.13%	0.11%	-18.35%	-0.40%	-2.67%
Cost of Revenue to Revenue	48.71%	48.26%	51.67%	50.37%	50.76%	49.71%	47.64%	50.34%	51.57%	53.18%	53.16%
SG&A Expenses to Revenue	10.45%	9.30%	13.07%	12.99%	11.04%	12.16%	14.06%	14.34%	13.03%	14.25%	15.14%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	45.10%	56.34%	47.50%	46.59%	45.26%	53.59%	52.46%	49.58%	47.14%	47.11%	48.90%
Earnings before Interest and Taxes (EBIT)	2.53	-3.93	-0.23	1.42	1.07	-2.50	-0.55	-0.35	0.40	-0.26	-0.93
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	3.48	-2.75	0.82	2.44	2.11	-1.22	0.51	0.71	1.62	0.87	0.15
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	2.29	2.47	2.70	2.85	2.58	1.73	1.65	1.32	1.38	1.09	0.84
Price to Tangible Book Value (P/TBV)	3.11	3.24	3.51	3.62	3.22	1.80	1.71	1.36	1.44	1.12	0.86
Price to Revenue (P/Rev)	0.24	0.26	0.28	0.31	0.29	0.20	0.19	0.17	0.16	0.14	0.11
Price to Earnings (P/E)	2.04	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	49.03%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	4.66	20.52	5.00	4.96	3.20	2.35	2.12	1.40	1.57	1.12	0.79
Enterprise Value to Revenue (EV/Rev)	0.17	0.16	0.22	0.26	0.26	0.15	0.15	0.14	0.13	0.10	0.08
Enterprise Value to EBITDA (EV/EBITDA)	4.20	14.03	12.27	11.98	18.46	6.66	6.86	11.64	12.92	4.51	3.66
Enterprise Value to EBIT (EV/EBIT)	8.42	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.67	13.03	22.65	28.66	50.42	18.84	22.42	103.47	0.00	61.92	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	2.66	2.92	13.80	26.48	0.00	0.00	13.96	0.00	13.35	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	1.10	3.29	34.69	0.00	0.00	0.00	0.00	0.00	21.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Financial Leverage	-1.29	-0.74	-0.60	-0.59	-0.46	-0.68	-0.49	-0.37	-0.30	-0.37	-0.33
Leverage Ratio	12.73	6.28	5.58	5.45	5.27	5.40	5.17	4.78	4.91	4.59	4.60
Compound Leverage Factor	12.72	6.30	5.84	-141.64	4.99	4.04	5.67	5.61	3.88	5.48	4.94
Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Altman Z-Score	13.12	11.54	12.62	12.77	12.91	13.44	13.60	14.30	14.50	14.54	14.62
Noncontrolling Interest Sharing Ratio	55.76%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.61	1.36	1.44	1.51	1.46	1.53	1.49	1.60	1.48	1.54	1.49
Quick Ratio	1.47	1.26	1.31	1.36	1.31	1.13	1.37	1.45	1.33	1.15	1.26
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-19	5.36	-0.39	-1.49	-7.62	-11	-3.97	-7.83	-1.91	-3.27	-3.66
Operating Cash Flow to CapEx	686.04%	327.85%	-1,084.19%	235.78%	-154.26%	646.17%	-794.17%	-2,155.56%	317.69%	51.83%	-165.71%
Free Cash Flow to Firm to Interest Expense	0.00	25.51	0.00	-0.04	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	20.80	0.00	0.04	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	14.45	0.00	0.02	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	1.77	1.58	1.66	1.67	1.71	1.65	1.69	1.71	1.66	1.65	1.63
Accounts Receivable Turnover	4.11	4.25	4.46	4.51	4.35	4.51	4.46	4.41	4.17	4.29	4.17
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	19.49	19.76	20.50	20.60	20.18	20.80	21.41	21.36	19.39	18.40	19.03
Accounts Payable Turnover	5.10	4.29	5.39	4.88	4.78	5.12	4.75	4.47	4.26	6.09	4.89
Days Sales Outstanding (DSO)	88.75	85.92	81.92	80.98	83.84	80.90	81.93	82.74	87.54	85.13	87.60
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	71.58	85.02	67.72	74.83	76.36	71.24	76.91	81.66	85.66	59.89	74.65
Cash Conversion Cycle (CCC)	17.17	0.89	14.20	6.14	7.48	9.65	5.02	1.08	1.88	25.23	12.95
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	7.22	1.49	8.50	9.63	15	12	12	17	13	15	16
Invested Capital Turnover	-77.41	38.54	23.23	22.25	16.81	27.97	17.32	12.90	11.72	11.96	11.09
Increase / (Decrease) in Invested Capital	20	-6.95	0.65	2.45	7.89	10	3.94	7.85	-1.74	3.18	3.13
Enterprise Value (EV)	34	31	43	48	48	28	26	25	21	17	12
Market Capitalization	47	49	54	59	54	38	35	29	28	22	17
Book Value per Share	$2.84	$2.75	$2.77	$2.85	$2.89	$2.98	$2.91	$3.02	$2.68	$2.77	$2.71
Tangible Book Value per Share	$2.09	$2.09	$2.13	$2.24	$2.31	$2.86	$2.80	$2.92	$2.59	$2.68	$2.63
Total Capital	21	20	20	21	21	22	21	22	20	21	20
Total Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Long-Term Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt	-13	-18	-11	-11	-5.94	-9.93	-8.98	-4.76	-6.51	-5.59	-4.54
Capital Expenditures (CapEx)	0.22	1.33	0.53	0.68	1.91	0.63	0.10	0.23	1.01	1.42	0.35
Debt-free, Cash-free Net Working Capital (DFCFNWC)	10	-1.26	6.15	7.66	11	8.54	8.65	14	9.19	11	11
Debt-free Net Working Capital (DFNWC)	23	17	18	19	17	18	18	19	16	16	15
Net Working Capital (NWC)	23	17	18	19	17	18	18	19	16	16	15
Net Nonoperating Expense (NNE)	0.09	0.38	0.43	29	0.12	1.35	0.36	0.36	-1.36	-2.28	0.09
Net Nonoperating Obligations (NNO)	-13	-18	-11	-11	-5.94	-9.93	-8.98	-4.76	-6.51	-5.59	-4.54
Total Depreciation and Amortization (D&A)	0.95	1.19	1.05	1.02	1.04	1.28	1.06	1.07	1.22	1.13	1.08
Debt-free, Cash-free Net Working Capital to Revenue	5.18%	-0.66%	3.24%	4.09%	5.83%	4.61%	4.77%	8.01%	5.51%	6.62%	6.77%
Debt-free Net Working Capital to Revenue	11.93%	8.93%	9.28%	9.96%	9.00%	9.97%	9.72%	10.73%	9.41%	10.12%	9.70%
Net Working Capital to Revenue	11.93%	8.93%	9.28%	9.96%	9.00%	9.97%	9.72%	10.73%	9.41%	10.12%	9.70%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.09	($0.27)	($0.02)	($3.84)	$0.02	($0.31)	($0.05)	($0.05)	($0.31)	$0.30	($0.08)
Adjusted Weighted Average Basic Shares Outstanding	7.24M	7.31M	7.24M	7.26M	7.32M	7.29M	7.36M	7.38M	7.42M	7.39M	7.42M
Adjusted Diluted Earnings per Share	$0.08	($0.26)	($0.02)	($3.84)	$0.02	($0.31)	($0.05)	($0.05)	($0.31)	$0.30	($0.08)
Adjusted Weighted Average Diluted Shares Outstanding	7.31M	7.31M	7.24M	7.37M	7.40M	7.29M	7.36M	7.38M	7.42M	7.39M	7.42M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	7.22M	7.24M	7.24M	7.29M	7.29M	7.36M	7.36M	7.41M	7.41M	7.41M	7.42M
Normalized Net Operating Profit after Tax (NOPAT)	2.04	2.39	0.86	1.26	1.91	-0.89	0.56	0.13	0.73	0.10	-0.43
Normalized NOPAT Margin	4.33%	4.82%	1.89%	2.80%	4.02%	-1.88%	1.34%	0.33%	1.85%	0.25%	-1.14%
Pre Tax Income Margin	5.37%	-7.97%	-0.53%	-81.80%	2.12%	-3.96%	-1.46%	-1.07%	0.81%	-0.77%	-2.68%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	-18.72	0.00	0.04	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	-7.59	0.00	0.03	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	-25.06	0.00	0.02	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	-13.94	0.00	0.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	10.67%	-150.96%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Financials Breakdown Chart

Key Financial Trends

Harte Hanks (NASDAQ: HHS) showed a mixed but improving operating picture in the most recent quarter, with Q1 2026 revenue holding up reasonably well even as profits turned negative again. The company generated $37.3 million in revenue, down from $39.9 million in Q4 2025 and $41.6 million in Q1 2025, while posting a $628,000 net loss versus $2.2 million net income in the prior quarter.

Over the last four quarters, Harte Hanks has struggled to produce consistent profitability. Revenue has generally been flat to lower, while operating expenses remain high relative to gross profit. That said, the company has shown some ability to generate cash in certain quarters, and its balance sheet still carries a meaningful equity base despite only modest total common equity on the reported balance sheet.

Q1 2026 gross profit remained solid at $17.5 million, showing the business still generates healthy margin dollars on a mid-30s million revenue base.
Cash flow from operations turned positive in some recent quarters, including $3.2 million in Q3 2025 and $737,000 in Q4 2025, indicating the business can still convert earnings into cash at times.
Total assets of $90.4 million in Q1 2026 provide a sizable asset base relative to the company’s current market scale.
Accounts receivable and deferred tax assets remain substantial, which may support near-term liquidity if collected and realized as expected.
Revenue has been relatively stable year over year, moving from $45.4 million in Q1 2024 to $37.3 million in Q1 2026, but the trend has not shown sustained growth.
Share count has stayed fairly steady around 7.4 million diluted shares in recent quarters, so there has not been major dilution pressure in the reported periods.
Balance sheet leverage is not extreme, but liabilities remain large at $70.3 million versus $20.1 million in common equity in Q1 2026.
Q1 2026 operating income was negative at -$768,000, showing the core business is still not consistently profitable.
Marketing expense remains very high relative to revenue, reaching $11.3 million in Q1 2026 and consuming a large share of gross profit.
Quarterly net income has been volatile, swinging from a $2.2 million profit in Q4 2025 to a $628,000 loss in Q1 2026 and larger losses in earlier 2025 quarters.

One of the most important trends is the deterioration from the stronger cash and earnings performance seen in late 2024 and parts of 2025. For example, Q4 2024 and Q3 2025 both showed periods of positive operating cash flow, but Q1 2026 reverted to negative operating cash flow of $575,000 and a $1.05 million decline in cash and equivalents. That points to ongoing pressure on working capital and profitability.

From a retail investor perspective, Harte Hanks looks like a company with some cash-generating capability, but also persistent cost pressure and inconsistent earnings. The key question going forward is whether management can stabilize operating margins and convert its gross profit into sustained operating income.

07/23/26 12:15 AM ETAI Generated. May Contain Errors.

Harte Hanks Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Harte Hanks' fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

Harte Hanks' net income appears to be on a downward trend, with a most recent value of -$811 thousand in 2025, falling from -$170.93 million in 2015. The previous period was -$30.30 million in 2024. See where experts think Harte Hanks is headed by visiting Harte Hanks' forecast page.

Harte Hanks' total operating income in 2025 was $386 thousand, based on the following breakdown:

Total Gross Profit: $78.75 million
Total Operating Expenses: $78.36 million

Over the last 10 years, Harte Hanks' total revenue changed from $444.17 million in 2015 to $159.57 million in 2025, a change of -64.1%.

Harte Hanks' total liabilities were at $71.30 million at the end of 2025, a 11.0% decrease from 2024, and a 74.0% decrease since 2015.

Over the last 10 years, Harte Hanks' book value per share changed from 2.29 in 2015 to 2.77 in 2025, a change of 20.8%.

Related Companies

Financial statements for NASDAQ:HHS last updated on 7/16/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Harte Hanks (HHS) Financials

Financials Breakdown Chart

Key Financial Trends

Harte Hanks Financials - Frequently Asked Questions

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Harte Hanks (HHS) Financials

Annual Income Statements for Harte Hanks

Quarterly Income Statements for Harte Hanks

Annual Cash Flow Statements for Harte Hanks

Quarterly Cash Flow Statements for Harte Hanks

Annual Balance Sheets for Harte Hanks

Quarterly Balance Sheets for Harte Hanks

Annual Metrics And Ratios for Harte Hanks

Quarterly Metrics And Ratios for Harte Hanks

Financials Breakdown Chart

Key Financial Trends

Harte Hanks Financials - Frequently Asked Questions

When does Harte Hanks' financial year end?

How has Harte Hanks' net income changed over the last 10 years?

What is Harte Hanks' operating income?

How has Harte Hanks' revenue changed over the last 10 years?

How much debt does Harte Hanks have?

How has Harte Hanks' book value per share changed over the last 10 years?

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools